Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, OTC

AV1 Group Announces the Launch of its New Proprietary Cannabis LED Solution


SAN DIEGO, May 18, 2017 /PRNewswire/ --

AV1 Group, Inc. (OTC Pink: AVOP), a publicly traded investment and holding company announced today that the Company, through a wholly owned subsidiary CannaLighting in partnership with Apollo Smart Lights, a provider of intelligent LED lighting solutions, has finished beta testing its proprietary prototype LED system for cannabis in Denver, Colorado and is preparing for launch of sales and marketing.

Apollo, who will manufacture the lighting product for the Company, has also granted the Company an exclusive license to market Apollo's line of products for Oregon, Washington, California, Nevada and Mexico; all prime cannabis growth territories.

The new LED system addresses and solves a key problem common to all 'horticulture' growers, the timing from vegetative to bloom. The system enables this process to proceed as quickly as possible and increases cost-effectiveness of the growth cycle.

The LED lighting sector is an intricate key to the indoor agricultural environments that these harvesting facilities represent, since the majority of these crops are grown indoors. U.S. retail cannabis sales will rise more than five-fold, from an estimated $2.2-$2.6 billion in 2014 to $7.4-8.2 billion in 2018, according to an article recently published by Marijuana Business Daily.

The Company further announced that it has landed its first sale of its proprietary LED system to an emerging private grow facility in Southern California, that is preparing to open a new facility that is 10 times its present footprint. Expected delivery in the next 45 days.

AV1 Group is actively continuing to develop the ventures recently announced, and intends to keep shareholders fully informed as projects unfold.

Lisa Landau, Director of Lighting, stated: "Now that the LED system has had a successful beta test, we are quickly transitioning into the sales and marketing of our new system. In addition to this initial sale, the Company is also conducting a test with another large scale commercial facility in Northern California."

For more information, please visit our corporate site: http://av1group.com/

Visit us on Facebook: https://www.facebook.com/AVOPGroup/
Visit us on Twitter: # https://twitter.com/av1_group
Visit us at Investors Hangout: https://m.investorshangout.com/AV1-Group-Inc-AVOP-58751/

Investors Hangout is the only authorized Investors blog page for AV1 Group, Inc.

About AV1 Group, Inc.:  

AV1 Group, Inc. is a publicly traded investment and holding company established to identify, secure, and monetize emerging growth companies, technologies and e-commerce businesses positioned for exponential growth. The Company seeks to discover inspired entrepreneurs with revolutionary concepts, which can make a substantial footprint in markets that the Company believes to have considerable growth potential. AV1 Group, Inc.'s comprehensive business model also includes a division which delivers internally created projects that are poised for revenue generation, and a platform enabling the Company to develop embryonic stage subsidiaries under one umbrella, bringing a spectrum of backgrounds to the table, thus providing a significant resource of experience, knowledge and expertise to every venture. AV1 Group, Inc. explores every opportunity to help each sector exceed their revenue goals while building close, active working relationships; preparing each respective division to be a robust competitor in their chosen markets. For more information, visit: http://www.av1group.com/

About CannaLighting: 

CannaLighting is a wholly-owned subsidiary of the Company. The CannaLighting sector of the corporate structure is actively building strategic relationships in the LED sector in accordance with a marketing model that, while requiring a minimal budget to launch, will yield the potential opportunity to be able to provide solutions for an ever increasing number of grow houses and cultivation centers nationally.

Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
AV1 Group, Inc.
+1-888-490-9997
For Investor Relations
Please email: [email protected]

http://www.av1group.com


SOURCE AV1 Group, Inc


These press releases may also interest you

at 06:15
The Barbara Ann Karmanos Cancer Institute welcomes Wasif Saif, M.D., MBBS, as the new leader of the Phase 1 Clinical Trials Multidisciplinary Team and co-leader of the Gastrointestinal (GI) and Neuroendocrine Oncology Multidisciplinary Team...

at 06:07
Seed Health will present new clinical data on its flagship innovation, DS-01® Daily Synbiotic, a 24-strain probiotic and prebiotic, at the upcoming 2024 Digestive Disease Week® (DDW) meeting. The presentations will highlight the results from two...

at 06:05
Arrowhead Pharmaceuticals, Inc. today announced that new interim clinical data on ARO-RAGE, an investigational RNAi-based medicine for the treatment of inflammatory lung diseases, such as asthma, were presented at the American Thoracic Society (ATS)...

at 06:00
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, will present new biomarker data suggesting that ALS patients may benefit from longer-term treatment with debamestrocel...

at 06:00
Ibex Medical Analytics (Ibex), a global leader in AI-powered cancer diagnostics, and Kameda Medical Center (Kameda), a leading Japanese institute at the pinnacle of healthcare innovation, today announced the publication of a clinical study evaluating...

at 06:00
HaemaLogiX Ltd, a clinical stage biotech developing novel immunotherapies for patients with blood cancers and B-cell diseases, is pleased to announce the appointment of Professor the Hon Greg Hunt, former Australian Federal Minister for Health, to...



News published on and distributed by: